Advances in diagnostic and surgical techniques have made significant contributions to improved survival of patients with congenital heart defects or acquired valvular heart disease. The survival rate of heart-transplant patients has also improved dramatically in recent years. As a result, many of these patients will present for non-cardiac surgery. The implications and potential risks associated with this patient population are reviewed.